Stay updated with breaking news from Opportunity Study. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- Sapience Therapeutics, Inc., a clinical-stage biotechnology company focused on the discovery and development of peptide therapeutics to address...
/PRNewswire/ -- Sapience Therapeutics, Inc., a clinical-stage biotechnology company focused on the discovery and development of peptide therapeutics to address...
A more nurturing approach is required to further rhino conservation, says a former head of conservation at SA National Parks.
Completion of the Phase 1 EPI-7386 combination study with Xtandi® (enzalutamide) expected in the third calendar quarter of 2023 followed by initiation of the...
Launched in April 1998, Charlotte Talks with Mike Collins has become the region's exclusive forum for the discussion of politics, arts, culture, social issues, literature, human interest, the environment and more.